Following any kind of intramuscular injection, it is possible for soreness, numbness, redness, itching, or bruising to develop at the injection site
Regenerative Medicine, 15(4), 567-579.
The authors reported that in obese mice, daily AOD-9604 administration over 14 days produced significant reductions in body weight gain, decreases in adipose tissue mass, and increases in fat oxidation, with effect sizes comparable to those of full-length human growth hormone [1]
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from licensed agents such as semaglutide or tirzepatide
Loading The Syringe And Preparing The Injection Site Follow the same instructions for Loading the Syringe and Preparing the Injection Site as outlined earlier